🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07257146
Enrolling by invitation Observational

Smart-SABI: Digital Phenotyping of Stroke Access Barriers

NCT07257146 · tracked via the Priya Life Science Egypt tracker
Phase
Observational
Started
2025-10-11
Last updated
2025-12-02

Condition(s) studied

StrokePracticeHealthcare DisparitiesThrombectomyHealthcare Access

Investigational drug(s) / intervention(s)

Targeted Stroke Systems of Care Training (SABI-Guided)

Targeted Stroke Systems of Care Training (SABI-Guided): Implementation of targeted barrier-reduction strategies at selected stroke centers based on baseline SABI profiles. The primary intervention consists of EMS Training Programs focused on stroke recognition, triage protocols, and rapid transport to Mechanical Thrombectomy (MT) capable centers. Comparator/Control: Pre-intervention period (historical control) where standard of care was utilized without the targeted SABI-guided training. Post-Intervention: Assessment of MT utilization rates and SABI scores following the implementation of the training modules.

Study summary

This study aims to identify and quantify the non-clinical barriers (social, transport, and knowledge-based) that delay patient arrival at the hospital during an Acute Ischemic Stroke. By utilizing a multimodal approach that combines a validated patient questionnaire (SABI Tool), Geographic Information Systems (GIS) analysis, and biological markers (infarct volume), the investigators seek to develop a Machine Learning model capable of predicting high-risk phenotypes for pre-hospital delay. The ultimate goal is to validate "Social Determinants of Health" against objective biological outcomes.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Diagnosis of Acute Ischemic Stroke (AIS) confirmed by neuroimaging (CT or MRI). Age $\\geq$ 18 years. Presentation to the Emergency Department within 7 days of symptom onset (to ensure recall accuracy). Patient or Legally Authorized Representative (LAR) able to provide informed consent. Verifiable residential address (required for GIS analysis). Exclusion Criteria: * In-hospital stroke onset. Stroke mimics (e.g., seizure, complex migraine, hypoglycemia). Hemorrhagic stroke. Homelessness or lack of fixed address (precludes geospatial analysis). Severe aphasia or cognitive deficit without an available surrogate/caregiver to complete the questionnaire.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Alexandria Stroke and Neurointervention Center Alexandria Egypt

More Middle East North Africa Stroke and Interventional Neurotherapies Organization trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07257146 on ClinicalTrials.gov ↗ ← All trials in Egypt